With extensive executive leadership across the gene therapy manufacturing industry, Raymond Kaczmarek serves as Chief Technical and Manufacturing Officer for Nanoscope Therapeutics. Prior to Nanoscope, he served as the Executive Chairman of the Board of Directors for Advanced Medicine Partners. Before this he was CEO of Genezen, a CDMO specializing in viral vector manufacturing services spanning process development, GMP viral vector manufacturing, and analytics. Before Genezen, Mr. Kaczmarek was Vice President of GMP operations at TriLink Biotechnologies, a CDMO specializing in the synthesis of nucleic acids, NTPs, and mRNA capping analogs with scale-up expertise and unique mRNA, oligonucleotide & plasmid production capabilities.

Mr. Kaczmarek also served as Vice President of Manufacturing and Supply Chain Operations at Pacira Biosciences, a leading provider of non-opioid pain management and regenerative health solutions, and also President of Nitto Avecia, a CDMO specializing in end-to-end solutions for oligonucleotide programs.  Mr. Kaczmarek holds a B.S. in Biology from Virginia Tech University.